Oxidative Stress is Predominant in Female but Not in Male Patients with Autoimmune Thrombocytopenia

Overview

Journal Oxid Med Cell Longev

Publisher Wiley

Specialties Cell Biology
Endocrinology

Date 2014 Apr 2

PMID 24688630

Citations 7

Authors

Julian Kamhieh-Milz

Abdulgabar Salama

Affiliations

Soon will be listed here.

Abstract

As the involvement of oxidative stress (OS) in autoimmune thrombocytopenia (AITP) has been reported, a fast and rapid test for the reliable measurement of OS and antioxidant capacities (AOCs) might be a useful tool in extending current diagnostic possibilities. The free oxygen radical test (FORT) and free oxygen radical defence (FORD) assay (Callegari, Italy) are easy to perform and reliable, with results available within 15 minutes. Thirty-seven AITP patients and 37 matched healthy individuals were included in this study. All participants responded to a standard questionnaire provided by these assays. Female patients with AITP were observed to demonstrate significantly higher OS in comparison to female controls (P = 0.0027) and male AITP patients (P = 0.0018). The AOCs were not reduced in patients with AITP (P = 0.7648). Correlation of OS with platelet count identified a weak positive correlation (P = 0.0327, Spearman R = 0.4672). The questionnaire revealed that ITP patients in comparison to healthy controls are more stressed, feel exhausted and fatigued, and eat a healthier diet. In conclusion, OS is predominant in female but not in male patients with AITP suggesting gender-specific differences in the pathomechanisms of AITP. Identification of patients with high levels of OS might be beneficial in the management of AITP.

Citing Articles

Analysis of Risk Factors and the Establishment of a Predictive Model for Thrombosis in Patients with Immune Thrombocytopenia.

Liang H, Duan L, Long M, Tie S, Sun C, Ma S Clin Appl Thromb Hemost. 2025; 31():10760296241301398.

PMID: 39763222 PMC: 11705361. DOI: 10.1177/10760296241301398.

Omega 3 fatty acids - Potential modulators for oxidative stress and inflammation in the management of sickle cell disease.

Khan S, Damanhouri G, Ahmed T, Halawani S, Ali A, Makki A J Pediatr (Rio J). 2022; 98(5):513-518.

PMID: 35139345 PMC: 9510794. DOI: 10.1016/j.jped.2022.01.001.

Oxidative Stress Is Increased in Combined Oral Contraceptives Users and Is Positively Associated with High-Sensitivity C-Reactive Protein.

Cauci S, Xodo S, Buligan C, Colaninno C, Barbina M, Barbina G Molecules. 2021; 26(4).

PMID: 33670593 PMC: 7921945. DOI: 10.3390/molecules26041070.

Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases.

Kander M, Cui Y, Liu Z J Cell Mol Med. 2016; 21(5):1024-1032.

PMID: 27957792 PMC: 5387169. DOI: 10.1111/jcmm.13038.

Oxidative Stress in Female Athletes Using Combined Oral Contraceptives.

Cauci S, Buligan C, Marangone M, Francescato M Sports Med Open. 2016; 2(1):40.

PMID: 27747795 PMC: 5031583. DOI: 10.1186/s40798-016-0064-x.

References

Schreck R, Rieber P, Baeuerle P . Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991; 10(8):2247-58. PMC: 452914. DOI: 10.1002/j.1460-2075.1991.tb07761.x. View

Akbayram S, Dogan M, Akgun C, Mukul Y, Peker E, Bay A . The association of oxidant status and antioxidant capacity in children with acute and chronic ITP. J Pediatr Hematol Oncol. 2010; 32(4):277-81. DOI: 10.1097/MPH.0b013e3181d6421f. View

George J, Woolf S, Raskob G, Wasser J, Aledort L, Ballem P . Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88(1):3-40. View

Jin C, Dong H, Cheng P, Zhou J, Zheng B, Liu F . Antioxidant status and oxidative stress in patients with chronic ITP. Scand J Immunol. 2013; 77(6):482-7. DOI: 10.1111/sji.12048. View

Ischiropoulos H, Gow A . Pathophysiological functions of nitric oxide-mediated protein modifications. Toxicology. 2005; 208(2):299-303. DOI: 10.1016/j.tox.2004.11.018. View

Emmerich F, Bal G, Barakat A, Milz J, Muhle C, Martinez-Gamboa L . High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. Br J Haematol. 2006; 136(2):309-14. DOI: 10.1111/j.1365-2141.2006.06431.x. View

Pers J, Daridon C, Devauchelle V, Jousse S, Saraux A, Jamin C . BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci. 2005; 1050:34-9. DOI: 10.1196/annals.1313.004. View

Ischiropoulos H . Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun. 2003; 305(3):776-83. DOI: 10.1016/s0006-291x(03)00814-3. View

Nussinovitch U, Shoenfeld Y . The role of gender and organ specific autoimmunity. Autoimmun Rev. 2011; 11(6-7):A377-85. DOI: 10.1016/j.autrev.2011.11.001. View

10.

Dreyer L, Prescott E, Gyntelberg F . Association between atherosclerosis and female lung cancer--a Danish cohort study. Lung Cancer. 2003; 42(3):247-54. DOI: 10.1016/s0169-5002(03)00295-2. View

11.

Kurien B, Hensley K, Bachmann M, Scofield R . Oxidatively modified autoantigens in autoimmune diseases. Free Radic Biol Med. 2006; 41(4):549-56. DOI: 10.1016/j.freeradbiomed.2006.05.020. View

12.

Kannan S . Free radical theory of autoimmunity. Theor Biol Med Model. 2006; 3:22. PMC: 1508139. DOI: 10.1186/1742-4682-3-22. View

13.

Poljsak B . Strategies for reducing or preventing the generation of oxidative stress. Oxid Med Cell Longev. 2011; 2011:194586. PMC: 3236599. DOI: 10.1155/2011/194586. View

14.

Kamhieh-Milz J, Bal G, Sterzer V, Kamhieh-Milz S, Arbach O, Salama A . Reduced antioxidant capacities in platelets from patients with autoimmune thrombocytopenia purpura (ITP). Platelets. 2011; 23(3):184-94. DOI: 10.3109/09537104.2011.610909. View

15.

Kurien B, Scofield R . Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev. 2008; 7(7):567-73. PMC: 2585037. DOI: 10.1016/j.autrev.2008.04.019. View

16.

Invernizzi P, Pasini S, Selmi C, Gershwin M, Podda M . Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun. 2009; 33(1):12-6. DOI: 10.1016/j.jaut.2009.03.005. View

17.

Moon E, Lee J, Oh S, Ryu S, Kim H, Kwak H . Reactive oxygen species augment B-cell-activating factor expression. Free Radic Biol Med. 2006; 40(12):2103-11. DOI: 10.1016/j.freeradbiomed.2006.02.007. View

18.

Coopamah M, Garvey M, Freedman J, Semple J . Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update. Transfus Med Rev. 2003; 17(1):69-80. DOI: 10.1053/tmrv.2003.50004. View

19.

Kim S, Angel P, Lafyatis R, Hattori K, Kim K, Sporn M . Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol. 1990; 10(4):1492-7. PMC: 362252. DOI: 10.1128/mcb.10.4.1492-1497.1990. View

20.

Meyer M, Schreck R, Baeuerle P . H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 1993; 12(5):2005-15. PMC: 413423. DOI: 10.1002/j.1460-2075.1993.tb05850.x. View